{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:27Z","timestamp":1790803287049,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.steroids.2024.109490","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T23:32:07Z","timestamp":1723591927000},"page":"109490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dehydroepiandrosterone supplementation improves diminished ovarian reserve clinical and in silico studies"],"prefix":"10.1016","volume":"211","author":[{"given":"Hani","family":"Moslem Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal J.M.","family":"Aldahham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanad","family":"Yakdhan Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2024.109490_b0005","unstructured":"Fertil. Steril.10332015 Mar 1e9e."},{"issue":"5","key":"10.1016\/j.steroids.2024.109490_b0010","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.fertnstert.2016.01.001","article-title":"Diminished ovarian reserve: is it a neglected cause in the assessment of recurrent miscarriage?","volume":"105","author":"Atasever","year":"2016","journal-title":"A Cohort Study. Fertility and Sterility."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40738-017-0041-1","article-title":"Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel\u2019s back","volume":"3","author":"Rasool","year":"2017","journal-title":"Fertility Research and Practice."},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0020","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.fertnstert.2014.12.093","volume":"103","year":"2015","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.fertnstert.2015.05.017","article-title":"Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System","volume":"104","author":"Devine","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2024.109490_b0030","series-title":"assisted reproductive technology success rates: national summary and fertility clinic reports","first-page":"2014","author":"Centers for Disease Control and Prevention. American Society for Reproductive Medicine, Society for Assisted Reproductive Technology","year":"2009"},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: a user\u2019s guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.steroids.2024.109490_b0040","first-page":"2014","article-title":"Decreasing quality of the new generations of anti-M\u00fcllerian hormone assays","volume":"11","author":"Lukaszuk","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0045","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-M\u00fcllerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.fertnstert.2014.10.037","article-title":"What is the \u201covarian reserve\u201d?","volume":"103","author":"Findlay","year":"2015","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/j.steroids.2024.109490_b0055","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.steroids.2024.109490_b0060","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.steroids.2024.109490_b0065","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-m\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.steroids.2024.109490_b0070","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"7","key":"10.1016\/j.steroids.2024.109490_b0075","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/humrep\/dew112","article-title":"Does anti-M\u00fcllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study","volume":"31","author":"Depmann","year":"2016","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.steroids.2024.109490_b0080","first-page":"393","article-title":"The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women","volume":"8","author":"Barbakadze","year":"2015","journal-title":"International Journal of Fertility & Sterility."},{"issue":"109","key":"10.1016\/j.steroids.2024.109490_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.maturitas.2017.11.014","article-title":"Testing ovarian reserve in pre-menopausal women: why, whom and how?","volume":"1","author":"Podfigurna","year":"2018","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.steroids.2024.109490_b0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/09513590.2014.893572","article-title":"Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period","volume":"30","author":"Grisendi","year":"2014","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5152\/jtgga.2012.28","article-title":"Evaluation of ovarian reserve in infertile patients","volume":"13","author":"Mutlu","year":"2012","journal-title":"Journal of the Turkish German Gynecological Association."},{"issue":"6","key":"10.1016\/j.steroids.2024.109490_b0100","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00404-014-3332-3","article-title":"Predictive value of anti-m\u00fcllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF\/ET","volume":"290","author":"Tsakos","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.steroids.2024.109490_b0105","first-page":"411","article-title":"An update on ovarian aging and ovarian reserve tests","volume":"9","author":"Amanvermez","year":"2016","journal-title":"International Journal of Fertility & Sterility."},{"issue":"9","key":"10.1016\/j.steroids.2024.109490_b0110","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/humrep\/deu139","article-title":"The Bologna criteria for the definition of poor ovarian responders: is there a need for revision?","volume":"29","author":"Ferraretti","year":"2014","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.steroids.2024.109490_b0115","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.fertnstert.2014.01.012","article-title":"Examining the ovaries by ultrasound for diagnosing hyperandrogenic anovulation: updating the threshold for newer machines","volume":"101","author":"Kollmann","year":"2014","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.steroids.2024.109490_b0120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, Eijkemans MJ, Mol BW, Broekmans FJ, IMPORT Study Group, Broer SL","year":"2013","journal-title":"Hum. Reprod. Update"},{"issue":"77","key":"10.1016\/j.steroids.2024.109490_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"1","author":"Burger","year":"2002","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/eje.0.1450103","article-title":"Dehydroepiandrosterone replacement therapy","volume":"145","author":"Gurnell","year":"2001","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.steroids.2024.109490_b0140","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s10815-013-0018-x","article-title":"Is there a role for DHEA supplementation in women with diminished ovarian reserve?","volume":"30","author":"Fouany","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"issue":"168","key":"10.1016\/j.steroids.2024.109490_b0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsbmb.2016.12.007","article-title":"Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology","volume":"1","author":"Labrie","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tjog.2014.07.007","article-title":"Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: A preliminary report and review","volume":"54","author":"Tsui","year":"2015","journal-title":"Taiwan. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol. Hum. Reprod."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-017-0326-3","article-title":"The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women","volume":"10","author":"Hu","year":"2017","journal-title":"Journal of Ovarian Research."},{"issue":"10","key":"10.1016\/j.steroids.2024.109490_b0165","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/humrep\/15.10.2129","article-title":"Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series","volume":"15","author":"Casson","year":"2000","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgyn.2016.01.002","article-title":"The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis","volume":"46","author":"Qin","year":"2017","journal-title":"Journal of Gynecology Obstetrics and Human Reproduction."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-018-0409-z","article-title":"Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study","volume":"16","author":"Chern","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"10","key":"10.1016\/j.steroids.2024.109490_b0180","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fendo.2019.00800","article-title":"Dehydroepiandrosterone supplementation improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve","volume":"15","author":"Chen","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejogrb.2013.04.003","article-title":"Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count","volume":"169","author":"Yilmaz","year":"2013","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-014-0093-3","article-title":"Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial","volume":"7","author":"Zhang","year":"2014","journal-title":"Journal of Ovarian Research."},{"issue":"6","key":"10.1016\/j.steroids.2024.109490_b0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rbmo.2015.03.002","article-title":"How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics","volume":"30","author":"Patrizio","year":"2015","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","article-title":"A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders","volume":"102","author":"Yeung","year":"2014","journal-title":"Fertil. Steril."},{"issue":"173","key":"10.1016\/j.steroids.2024.109490_b0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2013.11.008","article-title":"Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?","volume":"1","author":"Kara","year":"2014","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.rbmo.2014.10.005","article-title":"Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study","volume":"30","author":"Vlahos","year":"2015","journal-title":"Reprod. Biomed. Online"},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0215","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/14647273.2016.1262065","article-title":"Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders","volume":"20","author":"Triantafyllidou","year":"2017","journal-title":"Hum. Fertil."},{"issue":"7","key":"10.1016\/j.steroids.2024.109490_b0220","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/1471-0528.17045","article-title":"Effect of dehydroepiandrosterone administration before in vitro fertilization on the live birth rate in poor ovarian responders according to the Bologna criteria: A randomised controlled trial","volume":"129","author":"Wang","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.steroids.2024.109490_b0225","article-title":"World Medical Association publishes the Revised Declaration of Helsinki","author":"Pn","year":"2014","journal-title":"Natl. Med. J. India"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2024.109490_b0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(99)00238-5","article-title":"Follicle dynamics during ovarian ageing","volume":"163","author":"Faddy","year":"2000","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.steroids.2024.109490_b0235","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/humrep\/dey238","article-title":"Diminished ovarian reserve and poor response to stimulation in patients< 38 years old: a quantitative but not qualitative reduction in performance","volume":"33","author":"Morin","year":"2018","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0240","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","article-title":"The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0245","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0020-7292(99)00215-5","article-title":"Cost-effectiveness of IVF in women 38 years and older","volume":"69","author":"Suchartwatnachai","year":"2000","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.steroids.2024.109490_b0250","doi-asserted-by":"crossref","unstructured":"Ferraretti A, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of \u2018poor response'to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human reproduction. 2011 Jul 1;26(7):1616-24.","DOI":"10.1093\/humrep\/der092"},{"key":"10.1016\/j.steroids.2024.109490_b0255","series-title":"WHO laboratory manual for the examination and processing of human semen","first-page":"271","author":"World Health Organization","year":"2010"},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.steroids.2012.10.002","article-title":"DHEA metabolites activate estrogen receptors alpha and beta","volume":"78","author":"Miller","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2024.109490_b0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/bs.vh.2022.12.002","article-title":"Structure-function of DHEA binding proteins","volume":"123","author":"Clark","year":"2023","journal-title":"Vitam. Horm."},{"issue":"8","key":"10.1016\/j.steroids.2024.109490_b0270","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0969-2126(96)00098-6","article-title":"The structure of a complex of human 17\u03b2-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors","volume":"4","author":"Breton","year":"1996","journal-title":"Structure"},{"issue":"11","key":"10.1016\/j.steroids.2024.109490_b0275","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pcbi.0030217","article-title":"In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators","volume":"3","author":"Xie","year":"2007","journal-title":"PLoS Comput. Biol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0280","doi-asserted-by":"crossref","first-page":"975","DOI":"10.52711\/0974-360X.2023.00163","article-title":"Synthesis and Pharmacological Profile of Hydrazide Compounds","volume":"16","author":"Sadeek","year":"2023","journal-title":"Research Journal of Pharmacy and Technology"},{"key":"10.1016\/j.steroids.2024.109490_b0285","unstructured":"Ali, A., Saleh, M., & Owaid, K. (2023). Mild Synthesis, Characterization, and Application of some Polythioester Polymers Catalyzed by Cetrimide Ionic Liquid as a Green and Eco-Friendly Phase-Transfer Catalyst.Iranian Journal of Catalysis, doi: 10.30495\/ijc.2023.1973500.1977."},{"key":"10.1016\/j.steroids.2024.109490_b0290","doi-asserted-by":"crossref","unstructured":"Adasme,M. et al. PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucl. Acids Res. (05 May 2021), gkab294. doi: 10.1093\/nar\/gkab294.","DOI":"10.1093\/nar\/gkab294"},{"key":"10.1016\/j.steroids.2024.109490_b0295","article-title":"Ovarian reserve testing","author":"Parry","year":"2019","journal-title":"Endotext [internet]."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejogrb.2012.12.017","article-title":"DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism","volume":"168","author":"Hyman","year":"2013","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology."},{"issue":"6","key":"10.1016\/j.steroids.2024.109490_b0305","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0310","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.repbio.2017.01.006","article-title":"GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study","volume":"17","author":"Olgan","year":"2017","journal-title":"Reprod. Biol."},{"issue":"11","key":"10.1016\/j.steroids.2024.109490_b0315","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fendo.2020.00627","article-title":"Biological and clinical rationale for androgen priming in ovarian stimulation","volume":"4","author":"L\u00f8ssl","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0320","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11845-017-1665-1","article-title":"Association of basal serum androgen levels with ovarian response and ICSI cycle outcome","volume":"187","author":"Abide Yayla","year":"2018","journal-title":"Ir. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/19396368.2015.1011353","article-title":"Effects of dehydroepiandrosterone (DHEA) on follicular dynamics in a diminished ovarian reserve in vivo model","volume":"61","author":"Hassa","year":"2015","journal-title":"Syst. Biol. Reprod. Med."},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0330","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rbmo.2010.04.006","article-title":"Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation","volume":"21","author":"Gleicher","year":"2010","journal-title":"Reprod. Biomed. Online"},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0335","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13224-016-0941-8","article-title":"Evaluation of dehydroepiandrosterone supplementation on diminished ovarian reserve: a randomized, double-blinded, placebo-controlled study","volume":"67","author":"Agarwal","year":"2017","journal-title":"The Journal of Obstetrics and Gynecology of India."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-015-0056-6","article-title":"Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function","volume":"13","author":"Fang","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-018-0430-z","article-title":"Discordant anti-m\u00fcllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?","volume":"11","author":"Wang","year":"2018","journal-title":"Journal of Ovarian Research."},{"issue":"4","key":"10.1016\/j.steroids.2024.109490_b0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10815-014-0193-4","article-title":"Anti-M\u00fcllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF","volume":"31","author":"Lehmann","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"issue":"2","key":"10.1016\/j.steroids.2024.109490_b0355","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5653\/cerm.2019.46.2.50","article-title":"Clinical application of serum anti-M\u00fcllerian hormone in women","volume":"46","author":"Oh","year":"2019","journal-title":"Clin. Exp. Reprod. Med."},{"key":"10.1016\/j.steroids.2024.109490_b0360","doi-asserted-by":"crossref","unstructured":"Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, Barad D, Gleicher N, Hammes SR. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proceedings of the National Academy of Sciences. 2014 Feb 25;111(8):3008-13.","DOI":"10.1073\/pnas.1318978111"},{"issue":"4","key":"10.1016\/j.steroids.2024.109490_b0365","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/en.2016-1538","article-title":"Androgen stimulates growth of mouse preantral follicles in vitro: interaction with follicle-stimulating hormone and with growth factors of the TGF \u03b2 superfamily","volume":"158","author":"Laird","year":"2017","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.steroids.2024.109490_b0370","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-020-00569-6","article-title":"Role of anti-M\u00fcllerian hormone and testosterone in follicular growth: a cross-sectional study","volume":"20","author":"Lv","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"136","key":"10.1016\/j.steroids.2024.109490_b0380","article-title":"Impact of dehydroepianrosterone (DHEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): a dose-response meta-analysis of randomized controlled trials","volume":"15","author":"Xie","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"129","key":"10.1016\/j.steroids.2024.109490_b0385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.theriogenology.2019.02.005","article-title":"Immunohistochemical localization of insulin-like growth factor-1 (IGF-1) in the sheep ovary and the synergistic effect of IGF-1 and FSH on follicular development in vitro and LH receptor immunostaining","volume":"15","author":"Monte","year":"2019","journal-title":"Theriogenology"},{"issue":"8","key":"10.1016\/j.steroids.2024.109490_b0390","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1210\/jc.2014-1139","article-title":"IGF1R signaling is necessary for FSH-induced activation of AKT and differentiation of human Cumulus granulosa cells","volume":"99","author":"Baumgarten","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.steroids.2024.109490_b0395","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1071\/RD17332","article-title":"Insulin-like growth factor-1 (IGF-1) promotes primordial follicle growth and reduces DNA fragmentation through the phosphatidylinositol 3-kinase\/protein kinase B (PI3K\/AKT) signalling pathway","volume":"30","author":"Bezerra","year":"2018","journal-title":"Reprod. Fertil. Dev."},{"issue":"12","key":"10.1016\/j.steroids.2024.109490_b0400","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s10815-019-01618-3","article-title":"Insulin-like growth factor-1 and soluble FMS-like tyrosine kinase-1 prospectively predict cancelled IVF cycles","volume":"36","author":"Nasioudis","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"issue":"01","key":"10.1016\/j.steroids.2024.109490_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2096-2924.210696","article-title":"Effects of dehydroepiandrosterone on embryo quality and follicular fluid markers in patients with diminished ovarian reserves","volume":"1","author":"Fu","year":"2017","journal-title":"Reproductive and Developmental Medicine."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0410","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jc.2012-3071","article-title":"A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency","volume":"98","author":"Yeung","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.steroids.2024.109490_b0415","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: management of women with premature ovarian insufficiency","volume":"31","author":"Eshre Guideline Group on POI","year":"2016","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.steroids.2024.109490_b0420","first-page":"18","article-title":"The value of automated follicle volume measurements in IVF\/ICSI","volume":"28","author":"Vandekerckhove","year":"2014","journal-title":"Frontiers in Surgery."},{"issue":"6","key":"10.1016\/j.steroids.2024.109490_b0425","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.rbmo.2014.01.019","article-title":"Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles","volume":"28","author":"Zangmo","year":"2014","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.steroids.2024.109490_b0430","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.fertnstert.2013.12.032","article-title":"Female age-related fertility decline","volume":"101","author":"No","year":"2014","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.steroids.2024.109490_b0435","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1080\/07391102.2020.1851305","article-title":"Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study","volume":"40","author":"Aldahham","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.steroids.2024.109490_b0440","unstructured":"Qusay Falih, I., AH Alobeady, M., Banoon, S. R., & Saleh, M. Y. (2021). Role of Oxidized Low-density Lipoprotein in Human Diseases: A Review.Journal of Chemical Health Risks,11(Special Issue: Bioactive Compounds: Their Role in the Prevention and Treatment of Diseases), 71-83."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T16:33:22Z","timestamp":1725899602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X24001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":88,"alternative-id":["S0039128X24001284"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109490","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dehydroepiandrosterone supplementation improves diminished ovarian reserve clinical and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109490"}}